Global Small Molecule Anti-tumor Targted Drug Market Insights and Forecast to 2028

  • Report ID:191665
  • Industry Name: Pharma & Healthcare
  • Publishing Date: Apr-22
  • No. of Pages: 106
                              
Small Molecule Anti-tumor Targted Drug market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Small Molecule Anti-tumor Targted Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type EGFR ALK Bcr-Abl Others Segment by Application Liver Cancer Colorectal Cancer Lung Cancer Gastric Cancer Breast Cancer Esophageal Cancer Others By Company Astrazeneca Novartis Millennium Pharmaceuticals Bayer Exelixis Abbvie Boehringer-Ingelheim Eisai Pfizer Bristol-Myers Squibb Roche Bettapharma By Region North America United States Canada Europe Germany France UK Italy Russia Nordic Countries Rest of Europe Asia-Pacific China Japan South Korea Southeast Asia India Australia Rest of Asia Latin America Mexico Brazil Rest of Latin America Middle East & Africa Turkey Saudi Arabia UAE Rest of MEA
                        
1 Report Business Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Small Molecule Anti-tumor Targted Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 EGFR 1.2.3 ALK 1.2.4 Bcr-Abl 1.2.5 Others 1.3 Market by Application 1.3.1 Global Small Molecule Anti-tumor Targted Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Liver Cancer 1.3.3 Colorectal Cancer 1.3.4 Lung Cancer 1.3.5 Gastric Cancer 1.3.6 Breast Cancer 1.3.7 Esophageal Cancer 1.3.8 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Small Molecule Anti-tumor Targted Drug Market Perspective (2017-2028) 2.2 Small Molecule Anti-tumor Targted Drug Growth Trends by Region 2.2.1 Small Molecule Anti-tumor Targted Drug Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Small Molecule Anti-tumor Targted Drug Historic Market Size by Region (2017-2022) 2.2.3 Small Molecule Anti-tumor Targted Drug Forecasted Market Size by Region (2023-2028) 2.3 Small Molecule Anti-tumor Targted Drug Market Dynamics 2.3.1 Small Molecule Anti-tumor Targted Drug Industry Trends 2.3.2 Small Molecule Anti-tumor Targted Drug Market Drivers 2.3.3 Small Molecule Anti-tumor Targted Drug Market Challenges 2.3.4 Small Molecule Anti-tumor Targted Drug Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Small Molecule Anti-tumor Targted Drug Players by Revenue 3.1.1 Global Top Small Molecule Anti-tumor Targted Drug Players by Revenue (2017-2022) 3.1.2 Global Small Molecule Anti-tumor Targted Drug Revenue Market Share by Players (2017-2022) 3.2 Global Small Molecule Anti-tumor Targted Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Small Molecule Anti-tumor Targted Drug Revenue 3.4 Global Small Molecule Anti-tumor Targted Drug Market Concentration Ratio 3.4.1 Global Small Molecule Anti-tumor Targted Drug Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Small Molecule Anti-tumor Targted Drug Revenue in 2021 3.5 Small Molecule Anti-tumor Targted Drug Key Players Head office and Area Served 3.6 Key Players Small Molecule Anti-tumor Targted Drug Product Solution and Service 3.7 Date of Enter into Small Molecule Anti-tumor Targted Drug Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Small Molecule Anti-tumor Targted Drug Breakdown Data by Type 4.1 Global Small Molecule Anti-tumor Targted Drug Historic Market Size by Type (2017-2022) 4.2 Global Small Molecule Anti-tumor Targted Drug Forecasted Market Size by Type (2023-2028) 5 Small Molecule Anti-tumor Targted Drug Breakdown Data by Application 5.1 Global Small Molecule Anti-tumor Targted Drug Historic Market Size by Application (2017-2022) 5.2 Global Small Molecule Anti-tumor Targted Drug Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Small Molecule Anti-tumor Targted Drug Market Size (2017-2028) 6.2 North America Small Molecule Anti-tumor Targted Drug Market Size by Type 6.2.1 North America Small Molecule Anti-tumor Targted Drug Market Size by Type (2017-2022) 6.2.2 North America Small Molecule Anti-tumor Targted Drug Market Size by Type (2023-2028) 6.2.3 North America Small Molecule Anti-tumor Targted Drug Market Share by Type (2017-2028) 6.3 North America Small Molecule Anti-tumor Targted Drug Market Size by Application 6.3.1 North America Small Molecule Anti-tumor Targted Drug Market Size by Application (2017-2022) 6.3.2 North America Small Molecule Anti-tumor Targted Drug Market Size by Application (2023-2028) 6.3.3 North America Small Molecule Anti-tumor Targted Drug Market Share by Application (2017-2028) 6.4 North America Small Molecule Anti-tumor Targted Drug Market Size by Country 6.4.1 North America Small Molecule Anti-tumor Targted Drug Market Size by Country (2017-2022) 6.4.2 North America Small Molecule Anti-tumor Targted Drug Market Size by Country (2023-2028) 6.4.3 U.S. 6.4.4 Canada 7 Europe 7.1 Europe Small Molecule Anti-tumor Targted Drug Market Size (2017-2028) 7.2 Europe Small Molecule Anti-tumor Targted Drug Market Size by Type 7.2.1 Europe Small Molecule Anti-tumor Targted Drug Market Size by Type (2017-2022) 7.2.2 Europe Small Molecule Anti-tumor Targted Drug Market Size by Type (2023-2028) 7.2.3 Europe Small Molecule Anti-tumor Targted Drug Market Share by Type (2017-2028) 7.3 Europe Small Molecule Anti-tumor Targted Drug Market Size by Application 7.3.1 Europe Small Molecule Anti-tumor Targted Drug Market Size by Application (2017-2022) 7.3.2 Europe Small Molecule Anti-tumor Targted Drug Market Size by Application (2023-2028) 7.3.3 Europe Small Molecule Anti-tumor Targted Drug Market Share by Application (2017-2028) 7.4 Europe Small Molecule Anti-tumor Targted Drug Market Size by Country 7.4.1 Europe Small Molecule Anti-tumor Targted Drug Market Size by Country (2017-2022) 7.4.2 Europe Small Molecule Anti-tumor Targted Drug Market Size by Country (2023-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Small Molecule Anti-tumor Targted Drug Market Size (2017-2028) 8.2 Asia-Pacific Small Molecule Anti-tumor Targted Drug Market Size by Type 8.2.1 Asia-Pacific Small Molecule Anti-tumor Targted Drug Market Size by Type (2017-2022) 8.2.2 Asia-Pacific Small Molecule Anti-tumor Targted Drug Market Size by Type (2023-2028) 8.2.3 Asia-Pacific Small Molecule Anti-tumor Targted Drug Market Share by Type (2017-2028) 8.3 Asia-Pacific Small Molecule Anti-tumor Targted Drug Market Size by Application 8.3.1 Asia-Pacific Small Molecule Anti-tumor Targted Drug Market Size by Application (2017-2022) 8.3.2 Asia-Pacific Small Molecule Anti-tumor Targted Drug Market Size by Application (2023-2028) 8.3.3 Asia-Pacific Small Molecule Anti-tumor Targted Drug Market Share by Application (2017-2028) 8.4 Asia-Pacific Small Molecule Anti-tumor Targted Drug Market Size by Region 8.4.1 Asia-Pacific Small Molecule Anti-tumor Targted Drug Market Size by Region (2017-2022) 8.4.2 Asia-Pacific Small Molecule Anti-tumor Targted Drug Market Size by Region (2023-2028) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Small Molecule Anti-tumor Targted Drug Market Size (2017-2028) 9.2 Latin America Small Molecule Anti-tumor Targted Drug Market Size by Type 9.2.1 Latin America Small Molecule Anti-tumor Targted Drug Market Size by Type (2017-2022) 9.2.2 Latin America Small Molecule Anti-tumor Targted Drug Market Size by Type (2023-2028) 9.2.3 Latin America Small Molecule Anti-tumor Targted Drug Market Share by Type (2017-2028) 9.3 Latin America Small Molecule Anti-tumor Targted Drug Market Size by Application 9.3.1 Latin America Small Molecule Anti-tumor Targted Drug Market Size by Application (2017-2022) 9.3.2 Latin America Small Molecule Anti-tumor Targted Drug Market Size by Application (2023-2028) 9.3.3 Latin America Small Molecule Anti-tumor Targted Drug Market Share by Application (2017-2028) 9.4 Latin America Small Molecule Anti-tumor Targted Drug Market Size by Country 9.4.1 Latin America Small Molecule Anti-tumor Targted Drug Market Size by Country (2017-2022) 9.4.2 Latin America Small Molecule Anti-tumor Targted Drug Market Size by Country (2023-2028) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size (2017-2028) 10.2 Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size by Type 10.2.1 Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size by Type (2017-2022) 10.2.2 Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size by Type (2023-2028) 10.2.3 Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Share by Type (2017-2028) 10.3 Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size by Application 10.3.1 Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size by Application (2017-2022) 10.3.2 Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size by Application (2023-2028) 10.3.3 Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Share by Application (2017-2028) 10.4 Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size by Country 10.4.1 Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size by Country (2017-2022) 10.4.2 Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size by Country (2023-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Astrazeneca 11.1.1 Astrazeneca Company Details 11.1.2 Astrazeneca Business Overview 11.1.3 Astrazeneca Small Molecule Anti-tumor Targted Drug Introduction 11.1.4 Astrazeneca Revenue in Small Molecule Anti-tumor Targted Drug Business (2017-2022) 11.1.5 Astrazeneca Recent Developments 11.2 Novartis 11.2.1 Novartis Company Details 11.2.2 Novartis Business Overview 11.2.3 Novartis Small Molecule Anti-tumor Targted Drug Introduction 11.2.4 Novartis Revenue in Small Molecule Anti-tumor Targted Drug Business (2017-2022) 11.2.5 Novartis Recent Developments 11.3 Millennium Pharmaceuticals 11.3.1 Millennium Pharmaceuticals Company Details 11.3.2 Millennium Pharmaceuticals Business Overview 11.3.3 Millennium Pharmaceuticals Small Molecule Anti-tumor Targted Drug Introduction 11.3.4 Millennium Pharmaceuticals Revenue in Small Molecule Anti-tumor Targted Drug Business (2017-2022) 11.3.5 Millennium Pharmaceuticals Recent Developments 11.4 Bayer 11.4.1 Bayer Company Details 11.4.2 Bayer Business Overview 11.4.3 Bayer Small Molecule Anti-tumor Targted Drug Introduction 11.4.4 Bayer Revenue in Small Molecule Anti-tumor Targted Drug Business (2017-2022) 11.4.5 Bayer Recent Developments 11.5 Exelixis 11.5.1 Exelixis Company Details 11.5.2 Exelixis Business Overview 11.5.3 Exelixis Small Molecule Anti-tumor Targted Drug Introduction 11.5.4 Exelixis Revenue in Small Molecule Anti-tumor Targted Drug Business (2017-2022) 11.5.5 Exelixis Recent Developments 11.6 Abbvie 11.6.1 Abbvie Company Details 11.6.2 Abbvie Business Overview 11.6.3 Abbvie Small Molecule Anti-tumor Targted Drug Introduction 11.6.4 Abbvie Revenue in Small Molecule Anti-tumor Targted Drug Business (2017-2022) 11.6.5 Abbvie Recent Developments 11.7 Boehringer-Ingelheim 11.7.1 Boehringer-Ingelheim Company Details 11.7.2 Boehringer-Ingelheim Business Overview 11.7.3 Boehringer-Ingelheim Small Molecule Anti-tumor Targted Drug Introduction 11.7.4 Boehringer-Ingelheim Revenue in Small Molecule Anti-tumor Targted Drug Business (2017-2022) 11.7.5 Boehringer-Ingelheim Recent Developments 11.8 Eisai 11.8.1 Eisai Company Details 11.8.2 Eisai Business Overview 11.8.3 Eisai Small Molecule Anti-tumor Targted Drug Introduction 11.8.4 Eisai Revenue in Small Molecule Anti-tumor Targted Drug Business (2017-2022) 11.8.5 Eisai Recent Developments 11.9 Pfizer 11.9.1 Pfizer Company Details 11.9.2 Pfizer Business Overview 11.9.3 Pfizer Small Molecule Anti-tumor Targted Drug Introduction 11.9.4 Pfizer Revenue in Small Molecule Anti-tumor Targted Drug Business (2017-2022) 11.9.5 Pfizer Recent Developments 11.10 Bristol-Myers Squibb 11.10.1 Bristol-Myers Squibb Company Details 11.10.2 Bristol-Myers Squibb Business Overview 11.10.3 Bristol-Myers Squibb Small Molecule Anti-tumor Targted Drug Introduction 11.10.4 Bristol-Myers Squibb Revenue in Small Molecule Anti-tumor Targted Drug Business (2017-2022) 11.10.5 Bristol-Myers Squibb Recent Developments 11.11 Roche 11.11.1 Roche Company Details 11.11.2 Roche Business Overview 11.11.3 Roche Small Molecule Anti-tumor Targted Drug Introduction 11.11.4 Roche Revenue in Small Molecule Anti-tumor Targted Drug Business (2017-2022) 11.11.5 Roche Recent Developments 11.12 Bettapharma 11.12.1 Bettapharma Company Details 11.12.2 Bettapharma Business Overview 11.12.3 Bettapharma Small Molecule Anti-tumor Targted Drug Introduction 11.12.4 Bettapharma Revenue in Small Molecule Anti-tumor Targted Drug Business (2017-2022) 11.12.5 Bettapharma Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer
                
List of Tables Table 1. Global Small Molecule Anti-tumor Targted Drug Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of EGFR Table 3. Key Players of ALK Table 4. Key Players of Bcr-Abl Table 5. Key Players of Others Table 6. Global Small Molecule Anti-tumor Targted Drug Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 7. Global Small Molecule Anti-tumor Targted Drug Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 8. Global Small Molecule Anti-tumor Targted Drug Market Size by Region (2017-2022) & (US$ Million) Table 9. Global Small Molecule Anti-tumor Targted Drug Market Share by Region (2017-2022) Table 10. Global Small Molecule Anti-tumor Targted Drug Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 11. Global Small Molecule Anti-tumor Targted Drug Market Share by Region (2023-2028) Table 12. Small Molecule Anti-tumor Targted Drug Market Trends Table 13. Small Molecule Anti-tumor Targted Drug Market Drivers Table 14. Small Molecule Anti-tumor Targted Drug Market Challenges Table 15. Small Molecule Anti-tumor Targted Drug Market Restraints Table 16. Global Small Molecule Anti-tumor Targted Drug Revenue by Players (2017-2022) & (US$ Million) Table 17. Global Small Molecule Anti-tumor Targted Drug Revenue Share by Players (2017-2022) Table 18. Global Top Small Molecule Anti-tumor Targted Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule Anti-tumor Targted Drug as of 2021) Table 19. Ranking of Global Top Small Molecule Anti-tumor Targted Drug Companies by Revenue (US$ Million) in 2021 Table 20. Global 5 Largest Players Market Share by Small Molecule Anti-tumor Targted Drug Revenue (CR5 and HHI) & (2017-2022) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Small Molecule Anti-tumor Targted Drug Product Solution and Service Table 23. Date of Enter into Small Molecule Anti-tumor Targted Drug Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Small Molecule Anti-tumor Targted Drug Market Size by Type (2017-2022) & (US$ Million) Table 26. Global Small Molecule Anti-tumor Targted Drug Revenue Market Share by Type (2017-2022) Table 27. Global Small Molecule Anti-tumor Targted Drug Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 28. Global Small Molecule Anti-tumor Targted Drug Revenue Market Share by Type (2023-2028) Table 29. Global Small Molecule Anti-tumor Targted Drug Market Size by Application (2017-2022) & (US$ Million) Table 30. Global Small Molecule Anti-tumor Targted Drug Revenue Share by Application (2017-2022) Table 31. Global Small Molecule Anti-tumor Targted Drug Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 32. Global Small Molecule Anti-tumor Targted Drug Revenue Share by Application (2023-2028) Table 33. North America Small Molecule Anti-tumor Targted Drug Market Size by Type (2017-2022) & (US$ Million) Table 34. North America Small Molecule Anti-tumor Targted Drug Market Size by Type (2023-2028) & (US$ Million) Table 35. North America Small Molecule Anti-tumor Targted Drug Market Size by Application (2017-2022) & (US$ Million) Table 36. North America Small Molecule Anti-tumor Targted Drug Market Size by Application (2023-2028) & (US$ Million) Table 37. North America Small Molecule Anti-tumor Targted Drug Market Size by Country (2017-2022) & (US$ Million) Table 38. North America Small Molecule Anti-tumor Targted Drug Market Size by Country (2023-2028) & (US$ Million) Table 39. Europe Small Molecule Anti-tumor Targted Drug Market Size by Type (2017-2022) & (US$ Million) Table 40. Europe Small Molecule Anti-tumor Targted Drug Market Size by Type (2023-2028) & (US$ Million) Table 41. Europe Small Molecule Anti-tumor Targted Drug Market Size by Application (2017-2022) & (US$ Million) Table 42. Europe Small Molecule Anti-tumor Targted Drug Market Size by Application (2023-2028) & (US$ Million) Table 43. Europe Small Molecule Anti-tumor Targted Drug Market Size by Country (2017-2022) & (US$ Million) Table 44. Europe Small Molecule Anti-tumor Targted Drug Market Size by Country (2023-2028) & (US$ Million) Table 45. Asia Pacific Small Molecule Anti-tumor Targted Drug Market Size by Type (2017-2022) & (US$ Million) Table 46. Asia Pacific Small Molecule Anti-tumor Targted Drug Market Size by Type (2023-2028) & (US$ Million) Table 47. Asia Pacific Small Molecule Anti-tumor Targted Drug Market Size by Application (2017-2022) & (US$ Million) Table 48. Asia Pacific Small Molecule Anti-tumor Targted Drug Market Size by Application (2023-2028) & (US$ Million) Table 49. Asia Pacific Small Molecule Anti-tumor Targted Drug Market Size by Region (2017-2022) & (US$ Million) Table 50. Asia Pacific Small Molecule Anti-tumor Targted Drug Market Size by Region (2023-2028) & (US$ Million) Table 51. Latin America Small Molecule Anti-tumor Targted Drug Market Size by Type (2017-2022) & (US$ Million) Table 52. Latin America Small Molecule Anti-tumor Targted Drug Market Size by Type (2023-2028) & (US$ Million) Table 53. Latin America Small Molecule Anti-tumor Targted Drug Market Size by Application (2017-2022) & (US$ Million) Table 54. Latin America Small Molecule Anti-tumor Targted Drug Market Size by Application (2023-2028) & (US$ Million) Table 55. Latin America Small Molecule Anti-tumor Targted Drug Market Size by Country (2017-2022) & (US$ Million) Table 56. Latin America Small Molecule Anti-tumor Targted Drug Market Size by Country (2023-2028) & (US$ Million) Table 57. Middle East and Africa Small Molecule Anti-tumor Targted Drug Market Size by Type (2017-2022) & (US$ Million) Table 58. Middle East and Africa Small Molecule Anti-tumor Targted Drug Market Size by Type (2023-2028) & (US$ Million) Table 59. Middle East and Africa Small Molecule Anti-tumor Targted Drug Market Size by Application (2017-2022) & (US$ Million) Table 60. Middle East and Africa Small Molecule Anti-tumor Targted Drug Market Size by Application (2023-2028) & (US$ Million) Table 61. Middle East and Africa Small Molecule Anti-tumor Targted Drug Market Size by Country (2017-2022) & (US$ Million) Table 62. Middle East and Africa Small Molecule Anti-tumor Targted Drug Market Size by Country (2023-2028) & (US$ Million) Table 63. Astrazeneca Company Details Table 64. Astrazeneca Business Overview Table 65. Astrazeneca Small Molecule Anti-tumor Targted Drug Product Table 66. Astrazeneca Revenue in Small Molecule Anti-tumor Targted Drug Business (2017-2022) & (US$ Million) Table 67. Astrazeneca Recent Developments Table 68. Novartis Company Details Table 69. Novartis Business Overview Table 70. Novartis Small Molecule Anti-tumor Targted Drug Product Table 71. Novartis Revenue in Small Molecule Anti-tumor Targted Drug Business (2017-2022) & (US$ Million) Table 72. Novartis Recent Developments Table 73. Millennium Pharmaceuticals Company Details Table 74. Millennium Pharmaceuticals Business Overview Table 75. Millennium Pharmaceuticals Small Molecule Anti-tumor Targted Drug Product Table 76. Millennium Pharmaceuticals Revenue in Small Molecule Anti-tumor Targted Drug Business (2017-2022) & (US$ Million) Table 77. Millennium Pharmaceuticals Recent Developments Table 78. Bayer Company Details Table 79. Bayer Business Overview Table 80. Bayer Small Molecule Anti-tumor Targted Drug Product Table 81. Bayer Revenue in Small Molecule Anti-tumor Targted Drug Business (2017-2022) & (US$ Million) Table 82. Bayer Recent Developments Table 83. Exelixis Company Details Table 84. Exelixis Business Overview Table 85. Exelixis Small Molecule Anti-tumor Targted Drug Product Table 86. Exelixis Revenue in Small Molecule Anti-tumor Targted Drug Business (2017-2022) & (US$ Million) Table 87. Exelixis Recent Developments Table 88. Abbvie Company Details Table 89. Abbvie Business Overview Table 90. Abbvie Small Molecule Anti-tumor Targted Drug Product Table 91. Abbvie Revenue in Small Molecule Anti-tumor Targted Drug Business (2017-2022) & (US$ Million) Table 92. Abbvie Recent Developments Table 93. Boehringer-Ingelheim Company Details Table 94. Boehringer-Ingelheim Business Overview Table 95. Boehringer-Ingelheim Small Molecule Anti-tumor Targted Drug Product Table 96. Boehringer-Ingelheim Revenue in Small Molecule Anti-tumor Targted Drug Business (2017-2022) & (US$ Million) Table 97. Boehringer-Ingelheim Recent Developments Table 98. Eisai Company Details Table 99. Eisai Business Overview Table 100. Eisai Small Molecule Anti-tumor Targted Drug Product Table 101. Eisai Revenue in Small Molecule Anti-tumor Targted Drug Business (2017-2022) & (US$ Million) Table 102. Eisai Recent Developments Table 103. Pfizer Company Details Table 104. Pfizer Business Overview Table 105. Pfizer Small Molecule Anti-tumor Targted Drug Product Table 106. Pfizer Revenue in Small Molecule Anti-tumor Targted Drug Business (2017-2022) & (US$ Million) Table 107. Pfizer Recent Developments Table 108. Bristol-Myers Squibb Company Details Table 109. Bristol-Myers Squibb Business Overview Table 110. Bristol-Myers Squibb Small Molecule Anti-tumor Targted Drug Product Table 111. Bristol-Myers Squibb Revenue in Small Molecule Anti-tumor Targted Drug Business (2017-2022) & (US$ Million) Table 112. Bristol-Myers Squibb Recent Developments Table 113. Roche Company Details Table 114. Roche Business Overview Table 115. Roche Small Molecule Anti-tumor Targted Drug Product Table 116. Roche Revenue in Small Molecule Anti-tumor Targted Drug Business (2017-2022) & (US$ Million) Table 117. Roche Recent Developments Table 118. Bettapharma Company Details Table 119. Bettapharma Business Overview Table 120. Bettapharma Small Molecule Anti-tumor Targted Drug Product Table 121. Bettapharma Revenue in Small Molecule Anti-tumor Targted Drug Business (2017-2022) & (US$ Million) Table 122. Bettapharma Recent Developments Table 123. Research Programs/Design for This Report Table 124. Key Data Information from Secondary Sources Table 125. Key Data Information from Primary Sources List of Figures Figure 1. Global Small Molecule Anti-tumor Targted Drug Market Share by Type: 2021 VS 2028 Figure 2. EGFR Features Figure 3. ALK Features Figure 4. Bcr-Abl Features Figure 5. Others Features Figure 6. Global Small Molecule Anti-tumor Targted Drug Market Share by Application: 2021 VS 2028 Figure 7. Liver Cancer Case Studies Figure 8. Colorectal Cancer Case Studies Figure 9. Lung Cancer Case Studies Figure 10. Gastric Cancer Case Studies Figure 11. Breast Cancer Case Studies Figure 12. Esophageal Cancer Case Studies Figure 13. Others Case Studies Figure 14. Small Molecule Anti-tumor Targted Drug Report Years Considered Figure 15. Global Small Molecule Anti-tumor Targted Drug Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 16. Global Small Molecule Anti-tumor Targted Drug Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 17. Global Small Molecule Anti-tumor Targted Drug Market Share by Region: 2021 VS 2028 Figure 18. Global Small Molecule Anti-tumor Targted Drug Market Share by Players in 2021 Figure 19. Global Top Small Molecule Anti-tumor Targted Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule Anti-tumor Targted Drug as of 2021) Figure 20. The Top 10 and 5 Players Market Share by Small Molecule Anti-tumor Targted Drug Revenue in 2021 Figure 21. North America Small Molecule Anti-tumor Targted Drug Market Size YoY (2017-2028) & (US$ Million) Figure 22. North America Small Molecule Anti-tumor Targted Drug Market Size Market Share by Type (2017-2028) Figure 23. North America Small Molecule Anti-tumor Targted Drug Market Size Market Share by Application (2017-2028) Figure 24. North America Small Molecule Anti-tumor Targted Drug Market Size Share by Country (2017-2028) Figure 25. United States Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Canada Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Europe Small Molecule Anti-tumor Targted Drug Market Size YoY (2017-2028) & (US$ Million) Figure 28. Europe Small Molecule Anti-tumor Targted Drug Market Size Market Share by Type (2017-2028) Figure 29. Europe Small Molecule Anti-tumor Targted Drug Market Size Market Share by Application (2017-2028) Figure 30. Europe Small Molecule Anti-tumor Targted Drug Market Size Share by Country (2017-2028) Figure 31. Germany Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. France Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. U.K. Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Italy Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Russia Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Nordic Countries Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Asia-Pacific Small Molecule Anti-tumor Targted Drug Market Size YoY (2017-2028) & (US$ Million) Figure 38. Asia Pacific Small Molecule Anti-tumor Targted Drug Market Size Market Share by Type (2017-2028) Figure 39. Asia Pacific Small Molecule Anti-tumor Targted Drug Market Size Market Share by Application (2017-2028) Figure 40. Asia Pacific Small Molecule Anti-tumor Targted Drug Market Size Share by Region (2017-2028) Figure 41. China Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Japan Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. South Korea Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 44. Southeast Asia Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 45. India Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 46. Australia Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2017-2028) & (US$ Million) List of Figures Figure 47. Latin America Small Molecule Anti-tumor Targted Drug Market Size YoY (2017-2028) & (US$ Million) Figure 48. Latin America Small Molecule Anti-tumor Targted Drug Market Size Market Share by Type (2017-2028) Figure 49. Latin America Small Molecule Anti-tumor Targted Drug Market Size Market Share by Application (2017-2028) Figure 50. Latin America Small Molecule Anti-tumor Targted Drug Market Size Share by Country (2017-2028) Figure 51. Mexico Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 52. Brazil Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 53. Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size YoY (2017-2028) & (US$ Million) Figure 54. Middle East and Africa Small Molecule Anti-tumor Targted Drug Market Size Market Share by Type (2017-2028) Figure 55. Middle East and Africa Small Molecule Anti-tumor Targted Drug Market Size Market Share by Application (2017-2028) Figure 56. Middle East and Africa Small Molecule Anti-tumor Targted Drug Market Size Share by Country (2017-2028) Figure 57. Turkey Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 58. Saudi Arabia Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 59. UAE Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 60. Astrazeneca Revenue Growth Rate in Small Molecule Anti-tumor Targted Drug Business (2017-2022) Figure 61. Novartis Revenue Growth Rate in Small Molecule Anti-tumor Targted Drug Business (2017-2022) Figure 62. Millennium Pharmaceuticals Revenue Growth Rate in Small Molecule Anti-tumor Targted Drug Business (2017-2022) Figure 63. Bayer Revenue Growth Rate in Small Molecule Anti-tumor Targted Drug Business (2017-2022) Figure 64. Exelixis Revenue Growth Rate in Small Molecule Anti-tumor Targted Drug Business (2017-2022) Figure 65. Abbvie Revenue Growth Rate in Small Molecule Anti-tumor Targted Drug Business (2017-2022) Figure 66. Boehringer-Ingelheim Revenue Growth Rate in Small Molecule Anti-tumor Targted Drug Business (2017-2022) Figure 67. Eisai Revenue Growth Rate in Small Molecule Anti-tumor Targted Drug Business (2017-2022) Figure 68. Pfizer Revenue Growth Rate in Small Molecule Anti-tumor Targted Drug Business (2017-2022) Figure 69. Bristol-Myers Squibb Revenue Growth Rate in Small Molecule Anti-tumor Targted Drug Business (2017-2022) Figure 70. Roche Revenue Growth Rate in Small Molecule Anti-tumor Targted Drug Business (2017-2022) Figure 71. Bettapharma Revenue Growth Rate in Small Molecule Anti-tumor Targted Drug Business (2017-2022) Figure 72. Bottom-up and Top-down Approaches for This Report Figure 73. Data Triangulation Figure 74. Key Executives Interviewed

Purchase Report

Single User 3480
Multi User 5250
Corporate User 6960
Buy

Purchase Report

Customize the purchase as per your specific research needs:

  • 20% additional customization
  • Request for country level reports
  • Request for historical statistics
  • Additional company profile on request

Why Choose Our Report?

24/5 Research support

Get your queries resolved from an industry expert

Custom research service

Design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.